Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (0) | Back to Search
Antimicrobial stewardship program-led carbapenem restriction: a cost-effectiveness analysis
- At: 2017 FIP Congress in Seoul (South Korea)
- Type: Poster
- By: YOU, Joyce (The Chinese University of Hong Kong, School of Pharmacy, Shatin, Hong Kong SAR China)
- Co-author(s): Sheung-Yin Choi School of Pharmacy, The Chinese University of Hong Kong, Shatin, Hong Kong
BackgroundCarbapenem is typically reserved for treatment of multidrug-resistant pathogens, yet its usage has been increasing globally. Carbapenem misuse can lead to carbapenem-resistant Enterobacteriaceae. Antimicrobial stewardship program (ASP) aims to improve clinical outcomes and reduce antibiotic-associated Clostridium difficile infection.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.
Last update 4 October 2019